Pain Medicine · Wexford, PA
NPI
1922267327
Since 2008
Specialty
Pain Medicine
Code 208VP0000X
Group practices
7
Medicare group memberships
Hospitals
3
Hospital affiliations
7000 Stonewood Dr, Ste 151
Wexford, PA, 15090
Phone (724) 933-0300
Groups this clinician bills Medicare through
Medicare paid, 2024
$150K
1,681 services
Medicare patients, 2024
492
Average age 69
Drug cost, 2024
$2.0M
12,264 prescriptions
Company payments, 2024
$40.16
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin M Hibbard was code 80307 (drug tests), 350 times for 280 patients. In total Kevin M Hibbard billed 1,681 services in 47 codes, and Medicare paid $150K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-05-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 80307 Drug Tests | Office | 350 | 280 | $60.76 | $21K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 248 | 224 | $194.16 | $48K |
| 99214 Office E&M - Established | Office | 245 | 159 | $75.71 | $19K |
| 95886 Electrical Nerve Conductivity | Office | 165 | 82 | $63.71 | $11K |
| 99214 Office E&M - Established | Facility | 84 | 48 | $61.34 | $5,153 |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 56 | 51 | $112.14 | $6,280 |
| 64483 Nerve Block Injection - Back | Facility | 53 | 45 | $92.28 | $4,891 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 47 | 40 | $151.03 | $7,098 |
| 95911 Electrical Nerve Conductivity | Office | 39 | 39 | $129.86 | $5,065 |
| 99204 Office E&M - New | Office | 34 | 34 | $101.32 | $3,445 |
| 95910 Electrical Nerve Conductivity | Office | 28 | 28 | $114.43 | $3,204 |
| 99213 Office E&M - Established | Facility | 25 | 22 | $38.10 | $952 |
| 64493 Nerve Block Injection - Back | Facility | 24 | 18 | $61.85 | $1,484 |
| 64494 Nerve Block Injection - Back | Facility | 24 | 18 | $35.14 | $843 |
| 64484 Nerve Block Injection - Back | Facility | 23 | 21 | $34.54 | $794 |
By year: 2022 $150K for 2,365 services; 2023 $105K for 1,306 services; 2024 $150K for 1,681 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 350 | 280 | $60.76 | $21K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 248 | 224 | $194.16 | $48K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 56 | 51 | $112.14 | $6,280 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 47 | 40 | $151.03 | $7,098 |
Medicare prescription drug claims, 2024
In 2024, the drug Kevin M Hibbard prescribed most often to Medicare patients was Morphine Sulfate Er (Morphine Sulfate), with 2,130 prescriptions and refills. In total Kevin M Hibbard wrote 12,264 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Morphine Sulfate Er Morphine Sulfate | 2,130 | 2,143 | 490 | $62K |
| Gabapentin Generic | 1,861 | 2,154 | 519 | $32K |
| Pregabalin Generic | 1,591 | 1,748 | 434 | $45K |
| Xtampza Er Oxycodone Myristate | 1,396 | 1,399 | 406 | $829K |
| Celecoxib Generic | 712 | 810 | 233 | $20K |
| Fentanyl Generic | 688 | 688 | 130 | $66K |
| Oxycontin Oxycodone Hcl | 484 | 484 | 107 | $317K |
| Buprenorphine Generic | 450 | 450 | 162 | $109K |
| Duloxetine Hcl Generic | 347 | 415 | 94 | $3,433 |
| Tramadol Hcl Er Tramadol Hcl | 299 | 299 | 89 | $21K |
| Topiramate Generic | 235 | 302 | 66 | $1,572 |
| Meloxicam Generic | 230 | 273 | 81 | $968 |
| Tramadol Hcl Generic | 180 | 180 | 78 | $714 |
| Hysingla Er Hydrocodone Bitartrate | 170 | 170 | 52 | $139K |
| Lidocaine Generic | 136 | 144 | 49 | $12K |
Brand drugs: 2,544 claims; generic drugs: 9,720 claims; opioid claims: 6,114.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Kevin M Hibbard $40.16 ($40.16 in general payments such as food, travel and fees) from 1 company. The largest payer was Boston Scientific Corporation with $40.16.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 2 | $40.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.